Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Generation Bio Co. (GBIO : NSDQ)

• Company Description    Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo produced by a scalable capsid-free manufacturing process which uses proprietary cell-free rapid enzymatic synthesis. Generation Bio Co. is based in CAMBRIDGE, Mass. Number of Employees: 115

• Price / Volume Information    Yesterday's Closing Price: $0.37 Daily Weekly Monthly 20 Day Moving Average: 1,063,484 shares Shares Outstanding: 67.04 (millions) Market Capitalization: $25.00 (millions) Beta: 2.59 52 Week High: $3.65 52 Week Low: $0.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.64% -6.28% 12 Week -4.90% -20.01% Year To Date -64.82% -67.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 BINNEY STREET - CAMBRIDGE,MA 02142 USA ph: 617-655-7500 fax: - investors@generationbio.com http://www.generationbio.com

• General Corporate Information    Officers Geoff McDonough - Chief Executive Officer and President Kevin Conway - Chief Financial Officer Dannielle Appelhans - Director Ron H.W. Cooper - Director Jeffrey Jonas - Director Peer Information Generation Bio Co. (CORR.) Generation Bio Co. (RSPI) Generation Bio Co. (CGXP) Generation Bio Co. (BGEN) Generation Bio Co. (GTBP) Generation Bio Co. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 37148K100 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 67.04 Most Recent Split Date: (:1) Beta: 2.59 Market Capitalization: $25.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.34 Price/Cash Flow: - Price / Sales: 1.02 EPS Growth vs. Year Ago Period: 80.36% vs. Previous Quarter: 31.25% Sales Growth vs. Year Ago Period: 114.91% vs. Previous Quarter: 108.29% ROE 06/30/25 - - 03/31/25 - -75.84 12/31/24 - -120.23 ROA 06/30/25 - - 03/31/25 - -30.40 12/31/24 - -51.08 Current Ratio 06/30/25 - - 03/31/25 - 8.43 12/31/24 - 5.50 Quick Ratio 06/30/25 - - 03/31/25 - 8.43 12/31/24 - 5.50 Operating Margin 06/30/25 - - 03/31/25 - -292.92 12/31/24 - -661.91 Net Margin 06/30/25 - - 03/31/25 - -292.92 12/31/24 - -661.91 Pre-Tax Margin 06/30/25 - - 03/31/25 - -292.92 12/31/24 - -661.91 Book Value 06/30/25 - - 03/31/25 - 1.09 12/31/24 - 1.29 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©